• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基脲多中心研究中疼痛的气候和地理时间模式。

Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.

作者信息

Smith Wally R, Bauserman Robert L, Ballas Samir K, McCarthy William F, Steinberg Martin H, Swerdlow Paul S, Waclawiw Myron A, Barton Bruce A

机构信息

Virginia Commonwealth University, Internal Medicine - Division of Quality Health Care, 1200 E. Broad St. Richmond, VA 23298, USA.

出版信息

Pain. 2009 Nov;146(1-2):91-8. doi: 10.1016/j.pain.2009.07.008. Epub 2009 Aug 14.

DOI:10.1016/j.pain.2009.07.008
PMID:19683393
Abstract

No multi-site comparisons have tested whether seasonally cold temperature or climate exacerbate pain intensity in sickle cell disease (SCD). We examined seasonal SCD pain intensity and frequency patterns and compared them with concurrent climate conditions (temperature and barometric pressure) and geography of patient residence in the Multicenter Study of Hydroxyurea (MSH). We conducted a time series analysis of the monthly average daily pain intensity (0-9 scale) and pain frequency of the 299 MSH patients from December 1991 to December 1994. We used both an unobserved component model (UCM) and a nonparametric local regression (LOESS) to probe for a cycle and/or trend associated with the time series. We also examined base mixed regression models of season, monthly average temperature and barometric pressure, and geographic region as stand-alone predictors of pain intensity and frequency. Expanded models included additional predictor variables. UCM and LOESS analyses showed a cyclic pattern of pain intensity and frequency with peaks in late Fall/early Winter and troughs in Spring. Base regression models showed colder seasons were significantly associated with greater pain intensity (p = .0035) but not frequency (p = .07); higher monthly temperatures were significantly associated with both lower pain intensity and pain frequency, but higher monthly barometric pressures were significantly associated with greater pain intensity and frequency (all p's < .0001); and northern sites had nonsignificantly higher pain intensity (p = .40) and frequency (p = .07) than southern sites. This pattern of results did not change in expanded models including other predictors. Our results suggest that seasonably colder temperatures exacerbate sickle cell-related pain, but low barometric pressure does not, and geographic region of residence is not significantly related to pain in this sample.

摘要

尚无多中心比较研究检验季节性低温或气候是否会加剧镰状细胞病(SCD)的疼痛强度。在羟基脲多中心研究(MSH)中,我们研究了SCD疼痛强度和频率的季节性模式,并将其与同期气候条件(温度和气压)以及患者居住地理位置进行比较。我们对1991年12月至1994年12月期间299名MSH患者的月平均每日疼痛强度(0 - 9级)和疼痛频率进行了时间序列分析。我们使用未观察成分模型(UCM)和非参数局部回归(LOESS)来探究与时间序列相关的周期和/或趋势。我们还检验了季节、月平均温度和气压以及地理区域作为疼痛强度和频率独立预测因素的基础混合回归模型。扩展模型纳入了其他预测变量。UCM和LOESS分析显示疼痛强度和频率呈周期性模式,在秋末/初冬达到峰值,在春季达到低谷。基础回归模型显示较冷季节与更高的疼痛强度显著相关(p = .0035),但与疼痛频率无关(p = .07);月温度升高与更低的疼痛强度和疼痛频率均显著相关,但月气压升高与更高的疼痛强度和频率显著相关(所有p值 < .0001);北部地区的疼痛强度(p = .40)和频率(p = .07)略高于南部地区,但差异不显著。在纳入其他预测因素的扩展模型中,这种结果模式没有改变。我们的结果表明,季节性低温会加剧镰状细胞相关疼痛,但低气压不会,并且在该样本中居住地理位置与疼痛无显著相关性。

相似文献

1
Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.羟基脲多中心研究中疼痛的气候和地理时间模式。
Pain. 2009 Nov;146(1-2):91-8. doi: 10.1016/j.pain.2009.07.008. Epub 2009 Aug 14.
2
Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.患有镰状细胞贫血且经历疼痛危象的成年人接受羟基脲治疗的比例。
JAMA. 2015 Apr 28;313(16):1671-2. doi: 10.1001/jama.2015.3075.
3
Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.使用羟基脲的小儿镰状细胞病患者与未使用羟基脲的患者在生活质量上的差异。
Int J Health Care Qual Assur. 2014;27(6):468-81. doi: 10.1108/IJHCQA-01-2013-0008.
4
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.羟基脲与镰状细胞贫血。一种骨髓抑制性“转换”药物的临床应用。羟基脲治疗镰状细胞贫血多中心研究。
Medicine (Baltimore). 1996 Nov;75(6):300-26. doi: 10.1097/00005792-199611000-00002.
5
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.一项关于 l-谷氨酰胺在镰状细胞病中应用的 3 期临床试验。
N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971.
6
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.羟基脲对成年镰状细胞贫血患者死亡率和发病率的影响:长达9年治疗期的风险与益处
JAMA. 2003 Apr 2;289(13):1645-51. doi: 10.1001/jama.289.13.1645.
7
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.在尼日利亚北部的三个州,约4万名镰状细胞贫血患儿需要接受经颅多普勒超声(TCD)筛查,并使用羟基脲进行治疗以预防中风。
Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11.
8
Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.镰状细胞病患者的神经性疼痛:一项评估青少年和年轻人的横断面研究。
Ann Hematol. 2017 Jul;96(7):1121-1125. doi: 10.1007/s00277-017-2984-z. Epub 2017 Mar 30.
9
Daily home opioid use in adults with sickle cell disease: The PiSCES project.镰状细胞病成人患者的每日家庭阿片类药物使用情况:PiSCES项目
J Opioid Manag. 2015 May-Jun;11(3):243-53. doi: 10.5055/jom.2015.0273.
10
The impact of hydroxyurea on career and employment of patients with sickle cell anemia.羟基脲对镰状细胞贫血患者职业和就业的影响。
J Natl Med Assoc. 2010 Nov;102(11):993-9.

引用本文的文献

1
Mast cell extracellular trap formation underlies vascular and neural injury and hyperalgesia in sickle cell disease.肥大细胞细胞外陷阱的形成是导致镰状细胞病血管和神经损伤及痛觉过敏的基础。
Life Sci Alliance. 2024 Sep 6;7(11). doi: 10.26508/lsa.202402788. Print 2024 Nov.
2
Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.寒冷暴露会导致镰状细胞小鼠发生血管阻塞和疼痛,这一过程依赖于补体的激活。
Blood. 2023 Nov 30;142(22):1918-1927. doi: 10.1182/blood.2022019282.
3
Beyond Average: Providers' Assessments of Indices for Measuring Pain Intensity in Patients With Chronic Pain.
超越平均水平:医疗服务提供者对慢性疼痛患者疼痛强度测量指标的评估
Front Pain Res (Lausanne). 2021 Aug 12;2:692567. doi: 10.3389/fpain.2021.692567. eCollection 2021.
4
Diet and companionship modulate pain via a serotonergic mechanism.饮食和陪伴通过血清素能机制调节疼痛。
Sci Rep. 2021 Feb 1;11(1):2330. doi: 10.1038/s41598-021-81654-1.
5
III. Detecting Treatment Effects in Clinical Trials With Different Indices of Pain Intensity Derived From Ecological Momentary Assessment.三、从生态瞬时评估得出的不同疼痛强度指标在临床试验中检测治疗效果。
J Pain. 2021 Apr;22(4):386-399. doi: 10.1016/j.jpain.2020.10.003. Epub 2020 Oct 24.
6
I. Indices of Pain Intensity Derived From Ecological Momentary Assessments: Rationale and Stakeholder Preferences.一、基于生态瞬时评估的疼痛强度指标:原理和利益相关者偏好。
J Pain. 2021 Apr;22(4):359-370. doi: 10.1016/j.jpain.2020.08.003. Epub 2020 Sep 15.
7
Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.渐进性血管收缩伴序贯热刺激表明镰状细胞病存在血管自主神经功能障碍。
Blood. 2020 Sep 3;136(10):1191-1200. doi: 10.1182/blood.2020005045.
8
Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.综合方法治疗镰状细胞病疼痛:临床前和临床证据。
Complement Ther Med. 2020 Jun;51:102394. doi: 10.1016/j.ctim.2020.102394. Epub 2020 May 11.
9
Opioid Prescription Filling Trends Among Children with Sickle Cell Disease After the Release of State-Issued Guidelines on Pain Management.阿片类药物处方在发布州级疼痛管理指南后在镰状细胞病患儿中的填服趋势
Pain Med. 2020 Oct 1;21(10):2583-2592. doi: 10.1093/pm/pnaa002.
10
Geospatial Analyses of Pain Intensity and Opioid Unit Doses Prescribed on the Day of Discharge Following Orthopedic Surgery.骨科手术后出院当天疼痛强度和阿片类药物单位剂量的地理空间分析。
Pain Med. 2020 Aug 1;21(8):1644-1662. doi: 10.1093/pm/pnz311.